ÂÜÀòÂÒÂ×

Stephen M. Feinstone, MD, served from 2012 until his recent retirement as an adjunct professor in the Department of Biochemistry and Molecular Medicine at George Washington University. Prior to that, Dr. Feinstone worked as Chief at the Laboratory of Hepatitis Viruses, Division of Viral Products at the Center for Biologics Research and Review (CBER), a branch of the U.S. Food and Drug Administration (FDA). Dr. Feinstone also worked as Senior Investigator in the Laboratory of Infectious Diseases. In these roles, Dr. Feinstone’s work along with that of collaborators identified the virus that caused hepatitis type A and led to the development of the first licensed hepatitis A vaccine, HAVRIX. Further research led to the discovery of hepatitis C, and his more recent research focused on the virology and immunopathogenesis of hepatitis C virus infections and applying this information to experimental vaccine development. Dr. Feinstone received his undergraduate education at Johns Hopkins University and his medical degree from the University of Tennessee. He did his clinical training at the Medical College of Wisconsin in Milwaukee and at Georgetown University Hospital and the Washington Veterans Administration Hospital in Washington, DC.